Cargando…
The subcutaneous implantable cardioverter-defibrillator should be reserved for niche indications
Autores principales: | Yang, Yang, Birgersdotter-Green, Ulrika |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9626898/ https://www.ncbi.nlm.nih.gov/pubmed/36340490 http://dx.doi.org/10.1016/j.hroo.2022.09.005 |
Ejemplares similares
-
The subcutaneous implantable cardioverter-defibrillator should be considered for all patients with an implantable cardioverter-defibrillator indication
por: Tan, Jian Liang, et al.
Publicado: (2022) -
The wearable cardioverter-defibrillator is not needed for most high-risk patients
por: Bhatt, Advay G., et al.
Publicado: (2020) -
The wearable cardioverter-defibrillator is needed for most high-risk patients
por: Lee, Byron K.
Publicado: (2020) -
The Subcutaneous Implantable Cardioverter-Defibrillator: A Patient Perspective
por: Nesti, Martina, et al.
Publicado: (2023) -
Left atrial appendage occlusion should be offered only to select atrial fibrillation patients
por: Munir, Muhammad Bilal, et al.
Publicado: (2022)